Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
69.60
+0.62 (0.90%)
Oct 22, 2025, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $3.5 billion as of October 23, 2025. Its market cap has increased by 86.68% in one year.
Market Cap
3.50B
Enterprise Value
3.51B
1-Year Change
86.68%
Ranking
Category
Stock Price
$69.60
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $3.50B, an increase of 1,076.39%. That is a compound annual growth rate of 48.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 3.47B | 74.58% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | 510.71M | -7.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |